Immunovia, Inc. Receives Certificate of Registration – Clinical Laboratory Licensure Still Pending
LUND, SWEDEN – Immunovia AB (publ) (“Immunovia”), a diagnostic company that develops highly accurate blood tests for the early detection of cancer and autoimmune diseases, today announced that its American subsidiary Immunovia, Inc. has received CLIA Certificate of Registration Number 22D2227265. The Certificate of Registration is a critical step in the accreditation process of Immunovia, Inc.’s laboratory outside Boston. The Certificate of Registration is required by federal law and is a prerequisite to receiving a clinical laboratory licensure from Massachusetts Department of Public